# CIPN and it's Impact on Quality of Life in Patients Receiving Platinum and Taxanes

> **NCT05829967** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 60 (estimated)

## Conditions studied

- Chemotherapy-induced Peripheral Neuropathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05829967
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05829967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05829967, "CIPN and it's Impact on Quality of Life in Patients Receiving Platinum and Taxanes". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05829967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*